Pleomorphic xanthoastrocytoma: A comparative pathological study between conventional and anaplastic types

Histopathology

Volumn 52, Issue 2, 2008, Pages 183-193

  Hirose, T ^a   Ishizawa, K ^a   Sugiyama, K ^b   Kageji, T ^c   Ueki, K ^d   Kannuki, S ^e  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e Takamatsu Municipal Hospital   (Japan)

Author keywords

Anaplastic pleomorphic xanthoastrocytoma; Fluorescence in situ hybridization; Immunohistochemistry; Neuronal differentiation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTOMA; CASE REPORT; CELL DEATH; CELL PROLIFERATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; NERVE CELL DIFFERENTIATION; PHENOTYPE; PLEOMORPHIC XANTHOASTROCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; SCHOOL CHILD; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NECROSIS; NEURONS; PHENOTYPE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 37549052915     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02926.x     Document Type: Article

References (45)

1. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979 44 1839 1852.
2. Kepes JJ. Pleomorphic xanthoastrocytoma: the birth of a diagnosis and a concept. Brain Pathol. 1993 3 269 274.
3. Giannini C, Paulus W, Louis DN, Liberski P. Pleomorphic xanthoastrocytoma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK eds. World Health Organization classification of tumours. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon : IARC Press, 2007 22 24.
4. Furuta A, Takahashi H, Ikuta F et al. Temporal lobe tumor demonstrating ganglioglioma and pleomorphic xanthoastrocytoma components. J. Neurosurg. 1992 77 143 147.
5. Lindboe CF, Cappelen J, Kepes JJ. Pleomorphic xanthoastrocytoma as a component of a cerebellar ganglioglioma: case report. Neurosurgery 1992 31 353 355.
6. Vajtai I, Varga Z, Aguzzi A. Pleomorphic xanthoastrocytoma with gangliogliomatous component. Pathol. Res. Pract. 1997 193 617 621.
7. Perry A, Giannini C, Scheithauer BW et al. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Am. J. Surg. Pathol. 1997 21 763 771.
8. Evans AJ, Fayaz I, Cusimano MD, Laperriere N, Bilbao JM. Combined pleomorphic xanthoastrocytoma-ganglioglioma of the cerebellum. Arch. Pathol. Lab. Med. 2000 124 1707 1709.
9. Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am. J. Surg. Pathol. 1996 20 80 85.
10. Giannini C, Scheithauer BW, Lopes MBS et al. Immunophenotype of pleomorphic xanthoastrocytoma. Am. J. Surg. Pathol. 2002 26 479 485.
11. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch. Pathol. Lab. Med. 2003 127 1187 1191.
12. Giannini C, Scheithauer BW, Burger PC et al. Pleomorphic xanthoastrocytoma. What do we really know about it? Cancer 1999 85 2033 2045.
13. Weldon-Linne CM, Victor TA, Groothuis DR, Vick NA. Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery. Cancer 1983 52 2055 2063.
14. Kepes JJ, Rubinstein LJ, Ansbacher L, Schreiber DJ. Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases. Acta Neuropathol. 1989 78 585 593.
15. Macaulay RB, Jay V, Hoffman HJ, Becker LE. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report. J. Neurosurg. 1993 79 761 768.
16. Bayindir C, Balak N, Karasu A, Kasaroglu D. Anaplastic pleomorphic xanthoastrocytoma. Childs Nerv. Syst. 1997 13 50 56.
17. Leonard N, Alcutt DA, Farrell MA. Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosis. Histopathology 1998 32 375 378.
18. Tonn JC, Paulus W, Warmuth-Metz M et al. Pleomorphic xanthoastrocytoma: report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg. Neurol. 1997 47 162 169.
19. Prayson RA, Morris HH III. Anaplastic pleomorphic xanthoastrocytoma. Arch. Pathol. Lab. Med. 1998 122 1082 1086.
20. Sugita Y, Shigemori M, Okamoto K et al. Clinicopathological study of pleomorphic xanthoastrocytoma: correlation between histological features and prognosis. Pathol. Int. 2005 50 703 708.
21. Nasuha NA, Daud AH, Ghazali MM et al. Molecular genetic analysis of anaplastic pleomorphic xanthoastrocytoma. Asian J. Surg. 2003 26 120 125.
22. Tan TC, Ho LC, Yu CP, Cheung FC. Pleomorphic xanthoastrocytoma: report of two cases and review of the prognostic factors. J. Clin. Neurosci. 2004 11 203 207.
23. Lubansu A, Rorive S, David P et al. Cerebral anaplastic pleomorphic xanthoastrocytoma with meningeal dissemination at first presentation. Childs Nerv. Syst. 2004 20 119 122.
24. Nakajima T, Kumabe T, Shamoto H et al. Malignant transformation of pleomorphic xanthoastrocytoma. Acta Neurochir. (Wien) 2005 148 67 71.
25. de Tella OI Jr., Herculano MA, Prandini MN, Stavale JN, Aguiar PH. Malignant transformation of pleomorphic xanthoastrocytoma. Case report. Arq. Neuropsiquiatr. 2003 61 104 106.
26. Arita K, Kurisu K, Tominaga A et al. Intrasellar pleomorphic xanthoastrocytoma: case report. Neurosurgery 2002 51 1079 1082.
27. Ebato M, Tsunoda A, Maruki C, Ikeya F, Okada M. Distinctive pleomorphic xanthoastrocytoma-like tumor with exclusive abortive or aberrant neuronal differentiation and repeated recurrence. Case report. Neurol. Med. Chir. (Tokyo) 2002 42 399 405.
28. Shimada S, Ishizawa T, Ishizawa K et al. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum. Pathol. 2006 37 1123 1129.
29. Gil-Gouveia R, Cristino N, Farias JP et al. Pleomorphic xanthoasrocytoma of the cerebellum: illustrated review. Acta Neurochir. (Wien) 2004 146 1241 1244.
30. Wasdahl DA, Scheithauer BW, Andrews BT, Jeffrey RA Jr. Cerebellar pleomorphic xanthoastrocytoma: case report. Neurosurgery 1994 35 947 951.
31. Herpers MJHM, Freling G, Beuls EAM. Pleomorphic xanthoastrocytoma in the spinal cord. Case report. J. Neurosurg. 1994 80 564 569.
32. Zarate JO, Sampaolesi R. Pleomorphic xanthoastrocytoma of the retina. Am. J. Surg. Pathol. 1999 23 79 81.
33. Burger PC, Scheithauer BW, Vogel FS. Pleomorphic xanthoastrocytoma. Surgical pathology of the nervous system and its coverings, 4th edn. New York : Churchill Livingstone, 2002 215 220.
34. Kros JM, Vecht CJ, Stefanko SZ. The pleomorphic xanthoastrocytoma and its differential diagnosis: a study of five cases. Hum. Pathol. 1991 22 1128 1135.
35. Kordek R, Biernat W, Sapieja W, Alwasiak J, Liberski PP. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study. Acta Neuropathol. 1995 89 194 197.
36. Im SH, Chung CK, Kim SK et al. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes. J. Neuro-Oncol. 2004 66 17 27.
37. Hirose T, Giannini C, Scheithauer BW. Ultrastructural features of pleomorphic xanthoastrocytoma: a comparative study with glioblastoma multiforme. Ultrastruct. Pathol. 2001 25 469 478.
38. Dickerman RD, Anderson A, Morgan J, Cohen AJ. Diffuse malignant transformation of pleomorphic xanthoastrocytoma 21 years later: a matter of time? Acta Neurochir. (Wien) 2006 148 95 97.
39. Marton E, Feletti A, Orvieto E, Longatti P. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature. J. Neurol. Sci. 2007 252 144 153.
40. Reifenberger G, Kaulich K, Wiestler OD, Blumcke I. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas. Acta Neuropathol. 2003 105 358 364.
41. Kelley TW, Tubbs RR, Prayson RA. Molecular diagnostic techniques for the clinical evaluation of gliomas. Diagn. Mol. Pathol. 2005 14 1 8.
42. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK. Glioblastoma. In Kleihues P, Cavenee WK eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon : IARC Press, 2000 29 39.
43. Paulus W, Lisle DK, Tonn JC et al. Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol. 1996 91 293 297.
44. Kaulich K, Blaschke B, Numann A et al. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. J. Neuropathol. Exp. Neurol. 2002 61 1092 1099.
45. Giannini C, Hebrink D, Scheithauer BW, Dei Tos AP, James CD. Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma. Neurogenetics 2001 3 159 162.